preventive-medicine
(4)
Brian Finrow’s Second Draft of Biotech Starts With Spirulina
A corporate lawyer walked into a spirulina lab and stayed. At Lumen Bioscience, Brian Finrow is testing whether cheaper manufacturing can change not only how biologic drugs are made, but which problems the industry chooses to solve.
Wei-Wu He
Wei-Wu He is a scientist, inventor, entrepreneur and investor who serves as Executive Chairman and CEO of Human Longevity, Inc., the San Francisco Bay Area precision-health company that pairs whole-genome sequencing with advanced imaging and blood analytics to catch age-related disease early. Trained as a molecular biologist at Baylor College of Medicine with an MBA from Wharton, he was among the first scientists at Human Genome Sciences before building OriGene Technologies into a major research-tools business. Over three decades he has founded or funded dozens of biotech companies through his venture fund Emerging Technology Partners, and he now channels that experience into the science of extending healthy human lifespan.
Lifeforce
Lifeforce is a personalized health optimization and longevity-medicine platform that pairs at-home blood diagnostics measuring 40-50+ biomarkers with telehealth consults, a personal health coach, and tailored interventions including supplements, hormone protocols, and prescription medication. Co-founded in 2021 by Tony Robbins, Dr. Peter Diamandis, Dugal Bain-Kim, and Joel Jackson, the company aims to help people in midlife take a proactive, data-driven approach to feeling and functioning better rather than waiting for disease to show up.
Parsley Health
Parsley Health is a functional-medicine telehealth provider founded in 2016 by physician Dr. Robin Berzin. It pairs in-depth diagnostics and biomarker testing with longitudinal, team-based care - doctors plus health coaches - to find and treat the root causes of chronic conditions like gut, autoimmune, hormonal, metabolic and mental-health issues, rather than just managing symptoms. Originally a cash-pay membership model with clinics in New York and Los Angeles, Parsley has shifted to a virtual-first national service and in 2026 became the first functional-medicine provider to accept insurance in-network nationwide, putting its care within reach of roughly 150 million insured Americans.